Peter Heifetz Email

CEO . Orpro Therapeutics

Current Roles

Employees:
2
Revenue:
$155k
About
OrPro Therapeutics, Inc. is a San Diego preclinical-stage Johnson & Johnson JLABS alumni company addressing large unmet medical needs in acute and chronic respiratory, ophthalmology, and oncology with a cell-protective biologic drug platform based on the secreted human protein thioredoxin. Lead asset ORP100S has been shown to reduce inflammation, normalize mucociliary functions, and mitigate adverse effects of chemotherapy and radiation on stem cells in bone marrow and other sensitive organs through a novel covalent-binding mechanism that opens up disease-modifying treatment opportunities in obstructive, oxidative and inflammatory disorders, vision-threatening diseases of the retina, and cancer therapy.
Orpro Therapeutics Address
3210 Merryfield Row
SAN DIEGO, CA
Orpro Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.